Inflammatory eye reactions (IERs) are rare but have been associated with medications to
treat osteoporosis. The aim of this review is to summarize the current literature on the …

Ocular inflammatory reactions have been described in patients on bisphosphonate
treatment. We estimated the incidence rate of ocular inflammation at 3 and 12 months in …

Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …

To report two cases of bisphosphonate-induced orbital inflammation, discuss the clinic-
radiological features and management options, and highlight the increasing frequency of an …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Discussion Cases of ocular inflammation in patients taking bisphosphonates have been
reported since the early 1990s. 5, 6 Cases have involved both nitrogen and non-nitrogen …

Background Bisphosphonates are the most commonly used drugs to treat osteoporosis [1].
They are also used to treat other conditions featuring bone fragility such as osteitis …

Introduction: To present a series of patients with bisphosphonate induced orbital
inflammation, and to review the clinical presentation, radiological features, treatment options …

Objective To increase awareness of orbital inflammatory disease as a rare adverse effect of
bisphosphonates. Methods We present a case report and a review of the relevant literature …

Bisphosphonates are becoming more widespread as indications for them broaden. Several
ocular side effects due to bisphosphonates have been described, among the most …